Clinical trial
A Phase III Placebo-Controlled, Double-Blind Multi-Site Trial of Lofexidine for Opiate Withdrawal
NCT00032942 is registered in ClinicalTrials.gov with National Institute on Drug Abuse (NIDA) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase III Placebo-Controlled, Double-Blind Multi-Site Trial of Lofexidine for Opiate Withdrawal
- Lead sponsor
- National Institute on Drug Abuse (NIDA)
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- April 30, 2001
- Completion date
- Not reported
- Enrollment
- 66
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.